C
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Carol Morris's research focuses on the cellular and molecular mechanisms underlying ischemic retinopathies and multiple myeloma bone disease. Her work investigates the role of myeloid cells in inflammatory responses and tissue injury, particularly in the context of retinal ischemic events. Recent publications explore the arginase 1/ornithine decarboxylase pathway's function in suppressing inflammatory responses through the regulation of HDAC3 in myeloid cells, aiming to ameliorate retinal ischemic injury. Additionally, she has published on the deletion of myeloid HDAC3 to enhance efferocytosis and mitigate retinal ischemic injury.
Morris also contributes to the development and study of animal models for diseases, including multiple myeloma bone disease. Her research extends to developing methodologies for characterizing immune cells, such as a multi-color flow cytometry protocol for myeloid cells in mouse retina research. She is also involved in clinical research, contributing to a survey assessing equipoise for a randomized controlled trial on the treatment of bone metastases. Her scholarship metrics include an h-index of 25, with 80 total publications and 1,990 citations, designating her as a highly cited researcher. She collaborates with several researchers at the University of Arkansas for Medical Sciences, including Abdelrahman Y. Fouda, Esraa Shosha, Rami Ahmad Shahror, and Nancy J. Rusch.
Metrics
- h-index: 25
- Publications: 80
- Citations: 2,003
Selected Publications
-
Myeloid HDAC3 deletion protects against traumatic optic injury (2026)
-
HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis (2025)
-
The role of efferocytosis in ischemic stroke and insights from retinopathy (2025)
-
Disrupting the CD47/SIRPα Axis Protects Against Traumatic Optic Neuropathy (2025)
-
Disrupting the CD47/SIRPα Axis as a Novel and Translational Therapy for Stroke (Abstract ID: 161422) (2025)
-
Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology (2024)
-
Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury (2024)
-
Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions (2024)
-
The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury (2023)
-
Multi-color Flow Cytometry Protocol to Characterize Myeloid Cells in Mouse Retina Research (2023)
-
Herbal Extracts from Lycii Radicis Corex and Achyranthes japonica Prevent Multiple Myeloma (2021)
-
An Improved Animal Model of Multiple Myeloma Bone Disease (2021)
-
Animal Models of Multiple Myeloma Bone Disease (2021)
Collaboration Network
Top Collaborators
Abdelrahman Y. Fouda
9 shared publications
In database
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury
- Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury
- Multi-color Flow Cytometry Protocol to Characterize Myeloid Cells in Mouse Retina Research
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
Showing 5 of 9 shared publications
Esraa Shosha
7 shared publications
In database
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury
- Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- Disrupting the CD47/SIRPα Axis as a Novel and Translational Therapy for Stroke (Abstract ID: 161422)
Showing 5 of 7 shared publications
Rami Ahmad Shahror
University of Arkansas for Medical Sciences
6 shared publications
In database
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury
- Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury
- Multi-color Flow Cytometry Protocol to Characterize Myeloid Cells in Mouse Retina Research
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
Showing 5 of 6 shared publications
Nancy J. Rusch
University of Arkansas for Medical Sciences
5 shared publications
In database
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury
- Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury
- The role of efferocytosis in ischemic stroke and insights from retinopathy
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
Melissa Wild
University of Arkansas for Medical Sciences
5 shared publications
In database
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- Disrupting the CD47/SIRPα Axis Protects Against Traumatic Optic Neuropathy
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
Vincent Y. Ng
University of Maryland, Baltimore (US)
4 shared publications
- A survey to determine the zone of equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) randomized controlled trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
Thomas Schubert
UCLouvain (BE)
4 shared publications
- A survey to determine the zone of equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) randomized controlled trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
R. Lor Randall
UC Davis Health System (US)
4 shared publications
- A survey to determine the zone of equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) randomized controlled trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
Ricardo Becker
Hospital de Clínicas de Porto Alegre (BR)
4 shared publications
- A survey to determine the zone of equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) randomized controlled trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
Michelle Ghert
University of Maryland, Baltimore (US)
4 shared publications
- A survey to determine the zone of equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) randomized controlled trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
- A Survey to Determine the Zone of Equipoise for the Proximal FEmur Resection or Internal Fixation fOR Metastases (PERFORM) Randomized Controlled Trial
Donghoon Yoon
University of Arkansas for Medical Sciences
3 shared publications
In database
- Animal Models of Multiple Myeloma Bone Disease
- An Improved Animal Model of Multiple Myeloma Bone Disease
- Herbal Extracts from Lycii Radicis Corex and Achyranthes japonica Prevent Multiple Myeloma
Christian D. Mitchell
University of Arkansas for Medical Sciences
3 shared publications
In database
- Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions
- Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology
- HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis
Syed Hassan Mehdi
University of Arkansas for Medical Sciences
2 shared publications
In database
- Animal Models of Multiple Myeloma Bone Disease
- An Improved Animal Model of Multiple Myeloma Bone Disease
Syed J. Mehdi
University of Arkansas for Medical Sciences (US)
2 shared publications
- Animal Models of Multiple Myeloma Bone Disease
- Herbal Extracts from Lycii Radicis Corex and Achyranthes japonica Prevent Multiple Myeloma
Ruth B. Caldwell
Discovery Institute (US)
2 shared publications
- The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury
- Multi-color Flow Cytometry Protocol to Characterize Myeloid Cells in Mouse Retina Research
Similar Researchers
Based on overlapping research topics
Samuel L. Schach
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications
Simoes, Camila
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications
Andreea M. Bujor
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications
B.R. Hicks
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications
Thomas J. Kelly
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications
Haya Safar
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Molecular Biology Techniques and Applications
Cancer-related molecular mechanisms research